Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / AlphaCentric Advisors LLC
Form 13F · Q2 2026

AlphaCentric Advisors LLC

CIK 1913464Filed 2026-07-2413F-HR View the filing on EDGAR ↗
$118M
Reported book value
261
Positions
9
Quarters on record
Top 50
Positions

AlphaCentric Advisors LLC — holdings

Top 50 positions of 261, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1GILD Gilead Sciences Inc20,426+0.8%$3M2.2%
2VRTX Vertex Pharmaceuticals Inc5,002+1.4%$2M2.1%
3INVH Invitation Homes Inc73,000+0.0%$2M1.9%
4AZN Astrazeneca Plc11,394+1.4%$2M1.8%
5ROIV Roivant Sciences Ltd48,355+1.4%$2M1.4%
6ARGX Argenx Se1,806+0.7%$2M1.4%
7NBIX Neurocrine Biosciences Inc9,727+1.2%$2M1.4%
8INCY Incyte Corp14,451+1.4%$2M1.4%
9AXSM Axsome Therapeutics Inc.6,531+1.4%$2M1.4%
10APOGEE THERAPEUTICS INC Apogee Therapeutics Inc11,533+1.4%$2M1.3%
11EEFT Euronet Worldwide Inc20,000−28.2%$1M1.2%
12AEVA Aeva Technologies Inc50,000+0.0%$1M1.2%
13IWD Ishares Tr5,771−51.2%$1M1.2%
14IVZ Invesco Exchange Traded Fd T12,122−49.2%$1M1.2%
15QQQ Invesco Qqq Tr1,860—$1M1.2%
16IVZ Invesco Exch Traded Fd Tr Ii4,518—$1M1.2%
17BFS Saul Ctrs Inc35,000+0.0%$1M1.1%
18INSM Insmed Inc11,699+31.8%$1M1.1%
19IONS Ionis Pharmaceuticals Inc15,430−21.2%$1M1.0%
20ASND Ascendis Pharma A/S4,585—$1M1.0%
21PTGX Protagonist Therapeutics Inc9,171+1.4%$1M1.0%
22BLDR Builders Firstsource Inc12,500+25.0%$1M0.9%
23UMAC Unusual Machs Inc50,000+42.9%$1M0.9%
24HHH Howard Hughes Holdings Inc15,000—$1M0.9%
25ISHARES TR Ishares Tr12,954+36.9%$1M0.9%
26PSNL Personalis Inc78,924+23.3%$1M0.9%
27RYTM Rhythm Pharmaceuticals Inc9,449+1.6%$1M0.9%
28STXS Stereotaxis Inc600,000+0.0%$1M0.9%
29ROK Rockwell Automation Inc2,000+0.0%$990,1600.8%
30XMTR Xometry Inc10,000−20.0%$965,2000.8%
31ABBV Abbvie Inc3,613+1.9%$909,1750.8%
32JAZZ Jazz Pharmaceuticals Plc3,613+1.5%$870,6250.7%
33TEM Tempus Ai Inc15,000+50.0%$868,9500.7%
34PNNT Pennantpark Invt Corp250,000+60.3%$867,5000.7%
35AMGN Amgen Inc2,362+1.4%$855,3270.7%
36BIIB Biogen Inc3,891+1.5%$840,6890.7%
37AHRT Ah Rlty Tr Inc115,000+0.0%$814,2000.7%
38SMA Smartstop Self Storag Reit I25,000−16.7%$812,5000.7%
39RDW Redwire Corporation65,000+73.3%$794,9500.7%
40GMED Globus Med Inc10,000+33.3%$790,1000.7%
41CTO Cto Rlty Growth Inc New35,000−30.6%$752,8500.6%
42CATALYST PHARMACEUTICALS INC Catalyst Pharmaceuticals Inc23,622+1.4%$742,4390.6%
43ONDS Ondas Inc90,000+63.6%$741,6000.6%
44AAT American Assets Tr Inc30,000−14.3%$740,7000.6%
45HALO Halozyme Therapeutics Inc9,426+96.6%$737,7730.6%
46MGTX Meiragtx Hldgs Plc54,469+1.4%$735,8760.6%
47AXR Amrep Corp29,060−34.7%$732,8930.6%
48KRYS Krystal Biotech Inc1,945+1.4%$722,8980.6%
49MICC Magnum Ice Cream Co Nv40,000—$696,4000.6%
50MANH Manhattan Associates Inc5,000+42.9%$696,2500.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.